The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|9|1|32-71

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.1, 2009-02, pp. : 32-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New developments in the urokinase-type plasminogen activator system

By Rosenberg Steven  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 6, 2001-12 ,pp. : 711-722

Informa Healthcare

Access to resources Recommend Favorite

The Urokinase Plasminogen Activator System: Role in Malignancy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 39-49

Bentham Science Publishers

Access to resources Recommend Favorite

Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].

By  

Current Pharmaceutical Design, Vol. 9, Iss. 19, 2003-07 ,pp. : iv-iv

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin

By Dunbar S.D.   Ornstein D.L.   Zacharski L.R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. : 2085-2092

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic targets in oncology: urokinase-type plasminogen activator system

By Magill C.   Katz B.A.   Mackman R.L.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 109-133

Informa Healthcare

Access to resources Recommend Favorite